Neuroprotection and acute spinal cord injury: a reappraisal.
It has long been recognized that much of the post-traumatic degeneration of the spinal cord following injury is caused by a multi-factorial secondary injury process that occurs during the first minutes, hours, and days after spinal cord injury (SCI). A key biochemical event in that process is reactive oxygen-induced lipid peroxidation (LP). In 1990 the results of the Second National Acute Spinal Cord Injury Study (NASCIS II) were published, which showed that the administration of a high-dose regimen of the glucocorticoid steroid methylprednisolone (MP), which had been previously shown to inhibit post-traumatic LP in animal models of SCI, could improve neurological recovery in spinal-cord-injured humans. This resulted in the registration of high-dose MP for acute SCI in several countries, although not in the U.S. Nevertheless, this treatment quickly became the standard of care for acute SCI since the drug was already on the U.S. market for many other indications. Subsequently, it was demonstrated that the non-glucocorticoid 21-aminosteroid tirilazad could duplicate the antioxidant neuroprotective efficacy of MP in SCI models, and evidence of human efficacy was obtained in a third NASCIS trial (NASCIS III). In recent years, the use of high-dose MP in acute SCI has become controversial largely on the basis of the risk of serious adverse effects versus what is perceived to be on average a modest neurological benefit. The opiate receptor antagonist naloxone was also tested in NASCIS II based upon the demonstration of its beneficial effects in SCI models. Although it did not a significant overall effect, some evidence of efficacy was seen in incomplete (i.e., paretic) patients. The monosialoganglioside GM1 has also been examined in a recently completed clinical trial in which the patients first received high-dose MP treatment. However, GM1 failed to show any evidence of a significant enhancement in the extent of neurological recovery over the level afforded by MP therapy alone. The present paper reviews the past development of MP, naloxone, tirilazad, and GM1 for acute SCI, the ongoing MP-SCI controversy, identifies the regulatory complications involved in future SCI drug development, and suggests some promising neuroprotective approaches that could either replace or be used in combination with high-dose MP.
Hall
Edward D
ED
Spinal Cord and Brain Injury Research Center, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536, USA. edhall@uky.edu
Springer
Joe E
JE
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology
D018696:Neuroprotective Agents; D008775:Methylprednisolone
Cell. 2000 Jul 7;102(1):43-53
10929712
Neurol Res. 1997 Jun;19(3):289-99
9192382
J Neurotrauma. 2001 May;18(5):533-43
11393256
J Neurotrauma. 1992 Fall;9(3):245-53
1335518
Adv Exp Med Biol. 2002;507:397-401
12664616
J Neurosurg. 1985 Sep;63(3):390-7
3894597
J Neurosci. 1999 Jul 15;19(14):5932-41
10407032
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2007-12
9050895
Neuroscience. 2003;116(1):59-70
12535938
J Neurochem. 2000 Feb;74(2):740-53
10646526
EMBO J. 1998 Jan 2;17(1):37-49
9427739
Cell. 1996 Jul 12;86(1):147-57
8689682
J Neurosurg. 1992 Jan;76(1):13-22
1727150
Neurology. 1982 Jun;32(6):677-81
7201101
J Neurosurg. 1994 Jan;80(1):97-111
8271028
J Neurosurg. 1983 Aug;59(2):256-61
6864292
J Neurosurg. 1998 Dec;89(6):911-20
9833815
Exp Neurol. 1981 Jul;73(1):321-4
7250287
Exp Neurol. 1983 Oct;82(1):183-91
6628607
J Spinal Disord. 2000 Jun;13(3):185-99
10872756
J Neurosci Res. 1997 Dec 1;50(5):798-808
9418967
Science. 1995 Mar 31;267(5206):2003-6
7701324
Restor Neurol Neurosci. 2000;17(4):203-209
11490090
Oncogene. 1998 Oct 15;17(15):1959-68
9788439
EMBO J. 1998 Apr 15;17(8):2215-23
9545235
Trends Pharmacol Sci. 1992 Jan;13(1):29-35
1311880
Neurotoxicology. 1996 Fall-Winter;17(3-4):873-82
9086511
Exp Neurol. 1982 Jun;76(3):644-54
7084379
Lancet. 1981 Jul 25;2(8239):201
6114265
J Neurosci. 2003 Aug 6;23(18):6993-7000
12904460
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S56-7
11805611
J Neurotrauma. 1995 Jun;12(3):245-56
7473799
J Neurosci. 1997 Jul 15;17(14):5395-406
9204923
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S55
11805610
Nature. 2000 Dec 21-28;408(6815):1008-12
11140638
J Neurosurg. 1985 Nov;63(5):704-13
3903070
J Neurotrauma. 1995 Jun;12(3):235-43
7473798
Endocr Rev. 1986 Aug;7(3):284-301
3527687
Brain Res. 1985 Dec 16;359(1-2):300-5
4075151
J Neurotrauma. 2000 Oct;17(10):915-25
11063057
Science. 1997 Jan 31;275(5300):661-5
9005851
J Neurosurg. 2002 Apr;96(3 Suppl):259-66
11990832
Brain Res Brain Res Rev. 2003 May;42(2):169-85
12738057
J Neuroimmunol. 2000 Nov 1;111(1-2):122-30
11063829
J Pharmacol Exp Ther. 1988 Feb;244(2):423-7
2831338
EMBO J. 1999 Jan 15;18(2):330-8
9889190
Spinal Cord. 1998 Oct;36(10):683-90
9800272
J Neurochem. 1992 May;58(5):1730-5
1560229
Neurology. 2000 Dec 12;55(11):1649-55
11113218
J Neurosurg. 1992 Jan;76(1):23-31
1727165
Neuroscience. 2000;99(2):333-42
10938439
J Emerg Med. 1993;11 Suppl 1:43-8
8445202
J Neurosurg. 1983 Apr;58(4):538-42
6338168
Int Rev Neurobiol. 1982;23:165-95
6126462
JAMA. 1997 May 28;277(20):1597-604
9168289
Brain Res. 2001 Dec 27;923(1-2):163-71
11743984
J Neuropathol Exp Neurol. 1997 Dec;56(12):1323-38
9413281
Apoptosis. 2001 Aug;6(4):253-61
11445667
J Neurotrauma. 2001 May;18(5):523-32
11393255
J Neurochem. 1996 Mar;66(3):1125-30
8769875
J Neurosci Res. 2003 Jul 1;73(1):95-104
12815713
J Neurotrauma. 1998 Dec;15(12):1005-13
9872457
Methods Mol Biol. 2000;144:195-201
10818764
Adv Biochem Psychopharmacol. 1981;28:435-46
7211553
Chem Res Toxicol. 2000 Apr;13(4):294-300
10775330
J Neurotrauma. 2000 Oct;17(10):811-29
11063050
Exp Neurol. 1989 Sep;105(3):260-4
2767199
Arch Biochem Biophys. 1991 Aug 1;288(2):481-7
1654835
J Neurotrauma. 1998 Jul;15(7):459-72
9674550
Brain Res. 1989 May 8;486(2):228-35
2499400
Spinal Cord. 2000 May;38(5):273-86
10822400
J Neurosci. 2000 Oct 15;20(20):7622-30
11027222
Curr Opin Neurobiol. 1998 Oct;8(5):613-8
9811624
Adv Neurol. 1997;72:377-86
8993713
J Neurosurg. 1991 Jul;75(1):15-26
2045903
Neurochem Res. 2000 Oct;25(9-10):1191-8
11059793
Eur J Neurosci. 1999 Jul;11(7):2453-64
10383635
J Comput Aided Mol Des. 2001 Dec;15(12):1105-17
12160093
J Neurosci Res. 1996 Aug 15;45(4):349-63
8872895
Exp Neurol. 1996 Apr;138(2):261-76
8620925
Nature. 2001 Jul 5;412(6842):90-4
11452313
Ann N Y Acad Sci. 1999;890:120
10668419
Neurosurgery. 1982 Feb;10(2):227-31
7070619
J Neurosurg. 2000 Jul;93(1 Suppl):1-7
10879751
Surg Neurol. 1982 Nov;18(5):320-7
7179094
J Neurosurg. 1982 Nov;57(5):667-73
7131067
Neuroreport. 1998 Aug 3;9(11):2437-42
9721910
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S58-67
11805612
J Neurosurg. 1993 Oct;79(4):500-7
8410217
Neurol Med Chir (Tokyo). 2003 Jan;43(1):20-9; discussion 29-30
12568318
J Neurochem. 1999 Oct;73(4):1650-9
10501212
J Neurosci. 1998 Jul 1;18(13):4914-28
9634557
Nat Med. 1997 Jan;3(1):73-6
8986744
Ann Fr Anesth Reanim. 1998;17(2):114-22
9750706
N Engl J Med. 1999 Jun 10;340(23):1781-7
10362821
J Neurosci. 2000 Jan 15;20(2):2-8
10632601
Exp Neurol. 1994 Mar;126(1):61-75
8157127
J Pharmacol Exp Ther. 1987 Jul;242(1):137-42
3039107
Brain Res. 1981 Aug 3;217(2):412-5
7248798
Ann Emerg Med. 1993 Jun;22(6):987-92
8503537
Acta Neurol Scand. 1990 Jul;82(1):68-73
2239140
J Neurochem. 1985 Apr;44(4):1282-8
3882888
N Engl J Med. 1981 Oct 29;305(18):1063-7
6792542
Cell. 1997 Oct 17;91(2):231-41
9346240
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S68-86
11805613
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S47-54
11805609
Nature. 2000 Aug 24;406(6798):855-62
10972280
Nat Rev Mol Cell Biol. 2002 Jun;3(6):401-10
12042762
J Neurosurg. 1982 Jun;56(6):838-44
6281401
Ann N Y Acad Sci. 1999;890:261-9
10668431
CRC Crit Rev Clin Neurobiol. 1986;2(3):241-96
3536311
Exp Neurol. 1980 Apr;68(1):195-201
7363986
J Neurosurg. 1984 Jul;61(1):124-30
6374068
J Dev Physiol. 1991 Jan;15(1):53-9
1678755
J Neurochem. 1992 Sep;59(3):1033-40
1645163
J Neurosci Res. 2000 Jul 15;61(2):146-50
10878587
J Neurotrauma. 2003 Jan;20(1):59-67
12614588
Acta Physiol Scand Suppl. 1980;492:91-119
6939309
J Comp Neurol. 1997 Jan 20;377(3):443-64
8989657
J Neurotrauma. 2001 Apr;18(4):409-23
11336442
Biochimie. 2002 Feb-Mar;84(2-3):215-22
12022952
Mol Cell Biol. 1999 Aug;19(8):5800-10
10409766
J Neurosci Res. 1999 Sep 15;57(6):884-93
10467260
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S87-98
11805614
N Engl J Med. 1991 Jun 27;324(26):1829-38
2041549
FEBS Lett. 2000 Jul 7;476(3):118-23
10913597
J Neurosurg. 1998 Nov;89(5):699-706
9817404
Trends Pharmacol Sci. 2003 Jan;24(1):13-7
12498725
Res Publ Assoc Res Nerv Ment Dis. 1993;71:81-105
8380240
Nat Med. 1999 Aug;5(8):943-6
10426320
Free Radic Biol Med. 1989;6(3):303-13
2663663
JAMA. 1984 Jan 6;251(1):45-52
6361287
Acta Neurobiol Exp (Wars). 1990;50(4-5):515-21
2130666
Cell. 2000 Jul 7;102(1):33-42
10929711
Brain Res. 1995 Feb 20;672(1-2):177-86
7749740
Exp Neurol. 2000 Dec;166(2):213-26
11085887
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10824-9
10485910
J Neurochem. 2003 Feb;84(4):705-16
12562515
Mol Cell Biol. 1998 Jan;18(1):608-15
9418907
Exp Neurol. 2002 Sep;177(1):306-13
12429232
J Neurosci. 1998 Apr 15;18(8):2933-43
9526010
N Engl J Med. 1990 May 17;322(20):1405-11
2278545
J Cell Biol. 2001 Feb 5;152(3):483-90
11157976
Ann Surg. 1993 Oct;218(4):419-25; discussion 425-7
8215634
Cell Death Differ. 1999 Jun;6(6):516-24
10381654
J Neurosci Res. 2002 Apr 1;68(1):7-18
11933044
J Neurosurg. 1984 Aug;61(2):290-5
6539814
Curr Med Chem. 2000 Nov;7(11):1113-20
11032961
Prog Brain Res. 1987;71:203-8
3588943
J Neurosurg. 1987 Jul;67(1):102-5
3598657
Adv Biochem Psychopharmacol. 1981;28:421-34
7211552
Free Radic Biol Med. 1989;6(3):289-301
2663662
J Cereb Blood Flow Metab. 1998 Mar;18(3):248-56
9498841
J Neurosurg. 2002 Apr;96(3 Suppl):267-72
11990833
Exp Neurol. 1990 Oct;110(1):86-92
2209784
J Cereb Blood Flow Metab. 1998 Mar;18(3):238-47
9498840
Ann N Y Acad Sci. 1994 Nov 30;746:308-21; discussion 321-6
7825885
Nature. 2001 Mar 1;410(6824):112-6
11242052
Brain Res. 2001 Oct 19;916(1-2):115-26
11597598
Brain Res. 1988 May 17;448(2):287-93
3132308
Ann N Y Acad Sci. 1999;890:462-8
10668450
Cell. 1995 Dec 29;83(7):1253-62
8548811
Nature. 2001 Jul 5;412(6842):95-9
11452314
J Neurosurg. 1982 Jan;56(1):106-13
7054403
Clin Chem Lab Med. 2001 Apr;39(4):299-307
11388652
Mol Cell Biol. 1998 Apr;18(4):2143-52
9528786
J Neurosci. 2001 Jan 1;21(1):92-7
11150324
Cent Nerv Syst Trauma. 1985 Winter;2(4):257-67
3836012
Science. 1981 Jan 30;211(4481):493-4
7455690
EMBO J. 1997 Aug 1;16(15):4639-49
9303308
Cell Death Differ. 2000 Nov;7(11):1045-56
11139277
Prog Brain Res. 2002;137:37-47
12440358
Ann Thorac Surg. 1997 Nov;64(5):1279-85; discussion 1286
9386691
J Neurosci. 1997 Oct 1;17(19):7415-24
9295387
Ann N Y Acad Sci. 2001 Jun;939:436-49
11462799
Adv Pharmacol. 1994;28:221-68
8080818
Adv Neurol. 1988;47:523-30
3278529